Dates and Times
End Date: 1/20/2015
ObjectivesAs a result of this educational activity, webcast participants will be able to: UNDERSTAND the clinical presentation, diagnosis, and treatment options for patients with CML; IDENTIFY common toxicities and clinically significant drug interactions observed in patients receiving tyrosine kinase therapies; RECOGNIZE the need for long term therapy and ongoing patient education in CML; DISCUSS how to diagnose CLL; COMPREHEND the pronostic aspect of CLL.
The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians
The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.